Sort
65,743 grants matching “single cell sequencing”
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
$1,000,000Pan Zheng · Oncoc4, Inc. · R44 · FY2021 · CA
Comprehensive Discovery of Functional Elements of the Drosphila Transcriptome
$1,000,000Susan E Celniker · University Of Calif-Lawrenc Berkeley Lab · U54 · FY2012 · HG
Treatment of Peanut Allergy with Intradermal Administration of ASP0892 (ARA-LAMP-vax): A Randomized, Double-Blind, Placebo-Controlled, Phase I/II Study
$1,000,000Robert A Wood · Johns Hopkins University · UM2 · FY2020 · AI
Comprehensive, Flexible and FAIR Tools for the HuBMAP HIVE
$1,000,000Ziv Bar-Joseph · Carnegie-Mellon University · OT2 · FY2020 · OD
First in Human Phase I/II clinical trial of ONC-392: Preserving CTLA-4 immune tolerance checkpoint for safer and more effective cancer immunotherapy
$1,000,000Pan Zheng · Oncoc4, Inc. · R44 · FY2022 · CA
A 3D Tissue Map of the Human Lymphatic System
$1,000,000Mark A Atkinson · University Of Florida · U54 · FY2019 · AI
BIGDATA:F: Statistical and Computational Optimal Transport for Geometric Data Analysis
$1,000,000Justin M Solomon · Massachusetts Institute Of Technology · · FY2018 · CSE
Narrow-spectrum Agents Acting against Helicobacter pylori
$1,000,000Kenneth Coleman · Arietis · R44 · FY2015 · AI
Computational tools for uniform processing and integration of human reference atlas data [2 of 5]
$1,000,000Matthew Ruffalo · Carnegie-Mellon University · OT2 · FY2025 · OD
RIGERR: Resources for Investigating Genetic and Epigenetic Regulation of Renal Disease
$999,999Mingyu Liang · Medical College Of Wisconsin · RC2 · FY2022 · DK
Development of peptide nucleic acid antibiotics
$999,985Dev Priya Arya · Nubad, Llc · R42 · FY2021 · AI
Genetic Determinants of PAD
$999,964Stanford University · R01 · FY2004 · HL
Development of LNS8801 for cutaneous melanoma patients who cannot tolerate immunotherapy
$999,960Tina Garyantes · Linnaeus Therapeutics Inc · R44 · FY2025 · CA
DT-EGF Toxic Fusion Protein for the Treatment of Bladder Cancer
$999,955Mike Glode · Aurora Oncology, Inc. · R44 · FY2023 · CA
Mechanistic Signatures of Drug Responses in Cancer
$999,932Timothy J Mitchison · Harvard Medical School · RC2 · FY2009 · HG
Understanding protein folding, evolution and function via molecular simulation
$999,816Robert Best · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2023 · DK
Genetic Determinants of PAD
$999,727Stanford University · R01 · FY2003 · HL
SBIR Fast Track: Development of a High-throughput Magnetic Cytometer for Single Cell Sorting
$999,681Peng Paul Liu · Microsensor Labs, Llc · R44 · FY2022 · GM
Bedside to bench resources for lower urinary tract research
$999,601Douglas William Strand · Ut Southwestern Medical Center · RC2 · FY2025 · DK
Collaborative Research: Updating iVirus - the CyVerse-powered analytical toolkit for viruses of microbes
$999,570Matthew Sullivan · Ohio State University, The · · FY2022 · BIO
Pivots: Pivotal Pathways and Inclusive On-Ramps to Careers in Biomanufacturing
$999,558Laura Richane · Gloucester Marine Genomics Institute · · FY2023 · TIP
Development of peptide nucleic acid antibiotics
$999,557Dev Priya Arya · Nubad, Llc · R42 · FY2023 · AI
Phase 1/2a Clinical Study of Descartes-30 in Acute Respiratory Distress Syndrome
$999,491Charles Andrew Stewart · Cartesian Therapeutics, Inc. · R44 · FY2022 · HL
Dynamics of Protistan Grazers: Diversity, Abundance and Prey Relations
$999,445Rebecca J Gast · Woods Hole Oceanographic Institution · · FY2014 · GEO
i-AKC: Integrated AIRR Knowledge Commons
$999,330Lindsay G. Cowell · Ut Southwestern Medical Center · U24 · FY2023 · AI